Arbutus Biopharma Corp (NASDAQ:ABUS)
| 3.02 Delayed Data As of Mar 30 |  -0.08 / -2.58%Today’s Change | 1.85 Today|||52-Week Range 3.22 | +29.61% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 3.10 |
| Today’s open | 3.10 |
| Day’s range | 3.01 - 3.15 |
| Volume | 662,306 |
| Average volume (3 months) | 940,275 |
| Market cap | $487.7M |
Data as of 3:59pm ET, 03/30/2023
Growth & Valuation
| Earnings growth (last year) | +44.68% |
| Earnings growth (this year) | -26.96% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +255.11% |
| P/E ratio | NM |
| Price/Sales | 9.01 |
| Price/Book | 3.45 |
Financials
| Next reporting date | May 4, 2023 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $39.0M |
| Annual profit (last year) | -$69.5M |
| Net profit margin | -178.01% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |
Forecasts
